Briacell Therapeutics Corp (BCTX)

02:09 AM

BriaCell Therapeutics (NASDAQ:BCTX) Trading 4% Higher – Time to Buy? - Defense World

02:09 AM

Mar 31, 2025

(BCT) Technical Patterns and Signals (BCT:CA) - news.stocktradersdaily.com

Mar 31, 2025

Mar 28, 2025

BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail

Mar 28, 2025

Mar 27, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World

Mar 27, 2025

Mar 26, 2025

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025 - TipRanks

Mar 26, 2025

Mar 26, 2025

New Clinical Data: BriaCell's Registration Trial Results for Advanced Breast Cancer Treatment - Stock Titan

Mar 26, 2025

Mar 26, 2025

Where Will Rigetti Computing Stock Be in 1 Year? - The Globe and Mail

Mar 26, 2025

Mar 26, 2025

Dan Ives Is Pounding the Table on Microsoft Stock. Should You Buy the Dip? - The Globe and Mail

Mar 26, 2025

Mar 25, 2025

Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage? - The Globe and Mail

Mar 25, 2025

Mar 24, 2025

(BCT) Stock Evaluation Report (BCT:CA) - Stock Traders Daily

Mar 24, 2025

Mar 22, 2025

(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com

Mar 22, 2025

Mar 20, 2025

What To Expect From Carnival’s (CCL) Q1 Earnings - The Globe and Mail

Mar 20, 2025

Mar 20, 2025

BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Stocks In Play: BriaCell Therapeutics Corp By Baystreet.ca - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

(BCT) Technical Analysis and Trading Signals (BCT:CA) - Stock Traders Daily

Mar 20, 2025

Mar 20, 2025

BriaCell Therapeutics Corp - Baystreet.ca

Mar 20, 2025

Mar 20, 2025

Stocks in play: BriaCell Therapeutics Corp - The Globe and Mail

Mar 20, 2025

Mar 20, 2025

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer - MarketScreener

Mar 20, 2025

Mar 20, 2025

BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review - TipRanks

Mar 20, 2025

Mar 20, 2025

BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review - Investing.com

Mar 20, 2025

Mar 20, 2025

Second Data Safety Monitoring Board Issues Positive - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Major Milestone: BriaCell's Breast Cancer Immunotherapy Passes Critical Safety Review in Phase 3 Trial - Stock Titan

Mar 20, 2025

Mar 20, 2025

3 Reasons DRS is Risky and 1 Stock to Buy Instead - The Globe and Mail

Mar 20, 2025

Mar 17, 2025

Briacell Therapeutics Corp reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 17, 2025

Mar 16, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Growth in Short Interest - Defense World

Mar 16, 2025

Mar 14, 2025

Briacell Therapeutics Corp expected to post a loss of $1.12 a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 13, 2025

3 Industrials Stocks Walking a Fine Line - The Globe and Mail

Mar 13, 2025

Mar 13, 2025

BriaCell Therapeutics (OTCMKTS:BCTXF) Trading 0.3% Higher – Here’s Why - Defense World

Mar 13, 2025

Mar 13, 2025

BriaCell Therapeutics Reports Continued Financial Challenges - TipRanks

Mar 13, 2025

Mar 12, 2025

BriaCell subsidiary reports interim financial results By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

BriaCell Therapeutics Corp. SEC 10-Q Report - TradingView

Mar 12, 2025

Mar 12, 2025

BriaCell subsidiary reports interim financial results - Investing.com India

Mar 12, 2025

Mar 10, 2025

BriaCell Therapeutics (BCTX) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 10, 2025

Mar 03, 2025

BCTX stock touches 52-week low at $3.31 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

BCTX stock touches 52-week low at $3.31 amid sharp annual decline - Investing.com

Mar 03, 2025

Mar 02, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Significant Increase in Short Interest - Defense World

Mar 02, 2025

Mar 01, 2025

BriaCell Therapeutics (NASDAQ:BCTX) versus Actinium Pharmaceuticals (NYSE:ATNM) Critical Analysis - Defense World

Mar 01, 2025

Feb 25, 2025

Dye & Durham Limited - Baystreet.ca

Feb 25, 2025

Feb 22, 2025

(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily

Feb 22, 2025

Feb 20, 2025

(BCT) Market Performance Analysis (BCT:CA) - Stock Traders Daily

Feb 20, 2025

Feb 18, 2025

BriaCell Therapeutics Corp (NASDAQ: BCTX) – An Analysis Is What You Need - Stocks Register

Feb 18, 2025

Feb 18, 2025

(BCT) Investment Analysis (BCT:CA) - Stock Traders Daily

Feb 18, 2025

Feb 15, 2025

(BCT) Trading Advice (BCT:CA) - Stock Traders Daily

Feb 15, 2025

Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025

Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - MarketBeat

Feb 14, 2025

Feb 14, 2025

BriaCell regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia

Feb 14, 2025

Feb 13, 2025

BriaCell regains Nasdaq compliance with bid price - MSN

Feb 13, 2025

Feb 13, 2025

Briacell Therapeutics CorpRegains Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com

Feb 13, 2025